Search results for PX-TA1389

Showing 1 – 10 of1products
Opicinumab Biosimilar – Anti-LINGO1, LRRN6A, LERN1 mAb – Research Grade Brand Logo
ID: BAB868686263

Opicinumab Biosimilar – Anti-LINGO1, LRRN6A, LERN1 mAb – Research Grade, ProteoGenix, PX-TA1389

Description of Opicinumab Biosimilar - Anti-LINGO1, LRRN6A, LERN1 mAb - Research Grade General information on Anti-LINGO1/LRRN6A/LERN1[Homo sapiens] (Opicinumab) Monoclonal Antibody Opcinumab is investigated for the treatment of Central Nervous System (CNS) Demyelinating Disease and Multiple Sclerosis.

Host

Reactivity

Applications

Conjugation

Request a product

Please provide the required information below so that we can quickly source your products.